Table 3.
Expression levels of select DGAT2 mutations.
| Sample ID 1 | Sample Name | Mutation | Mutation Z-Score | Sample Z-Sore Range 2 |
|---|---|---|---|---|
| COSU540 | Cecum carcinoma | p.G120D | 2.221 | 0.30 ± 4.68 |
| COSU413 3 | Bladder urothelial carcinoma | p.P275= | 2.335 | 0.19 ± 1.19 |
| COSU418 | Lung squamous cell carcinoma | p.P141S | 2.583 | 0.07 ± 1.18 |
| COSU419 | Uterine corpus endometrial carcinoma | p.R189W | 2.706 | 0.22 ± 1.19 |
| COSU540 | Cecum carcinoma | p.R218W | 3.292 | 0.30±4.68 |
| COSU418 | Lung squamous cell carcinoma | p.W40* | 3.368 | 0.07 ± 1.18 |
| COSU435 | Prostate adenocarcinoma | p.G167D | 3.647 | 0.05 ± 1.05 |
| COSU377 | Acute myeloid leukemia | c.*27A>G | 4.978 | 0.0040 ± 0.98 |
| COSU414 | Breast invasive carcinoma | p.I94V | 5.195 | 0.140 ± 2.34 |
| COSU419 | Uterine corpus endometrial carcinoma | c.*556A>T | 6.743 | 0.22 ± 1.19 |
1See Supplementary Figure S3B for tissue information on Sample ID. 2 See Supplementary Figure S3A for extended information on Z-score range. 3 Red samples are statistically significant.